Wird geladen...
Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury
Traumatic brain injury (TBI) in various forms affects millions in the United States annually. There are currently no FDA-approved therapies for acute injury or the chronic comorbidities associated with TBI. Acute phases of TBI are characterized by profound neuroinflammation, a process that stimulate...
Gespeichert in:
| Veröffentlicht in: | Front Behav Neurosci |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985078/ https://ncbi.nlm.nih.gov/pubmed/32038189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnbeh.2019.00287 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|